Table 2 Relative risk of renal cell cancer associated with standardised measured blood pressure and self reported blood pressure medication

From: Blood pressure and renal cancer risk: the HUNT Study in Norway

 

Women

Men

Variable

Person years

Cases

RR a

95% CI

P trend b

Person years

Cases

RR a

95% CI

P trend b

Systolic blood pressure (mm Hg)

 <130

304 754

13

1.0

(Reference)

200 863

31

1.0

(Reference)

 130–149

145 513

26

1.7

(0.9–3.5)

223 960

40

0.8

(0.5–1.4)

 150–169

73 828

24

2.0

(0.9–4.2)

81 183

35

1.2

(0.7–2.0)

170

53 060

22

2.0

(0.9–4.6)

0.11

33 890

18

1.0

(0.5–1.9)

0.59

Diastolic blood pressure (mm Hg)

 <85

346 610

31

1.0

(Reference)

264 778

41

1.0

(Reference)

 85–94

145 246

22

0.8

(0.5–1.5)

173 219

56

1.6

(1.0–2.3)

 95–104

64 349

22

1.4

(0.8–2.5)

76 975

20

1.0

(0.6–1.7)

105

20 950

10

1.6

(0.8–3.5)

0.13

24 924

7

0.9

(0.4–2.0)

0.49

Blood pressure medication c

 No

504 135

57

1.0

(Reference)

499 677

106

1.0

(Reference)

 Yes

73 020

28

1.4

(0.8–2.2)

40 219

18

1.1

(0.6–1.8)

  1. CI=confidence interval, RR=relative risk.
  2. aAdjusted for age, blood pressure medication (no, yes), body mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0), smoking status (never, former, current, unknown), education (<10, 10–12, 13 years, unknown).
  3. bP-values from trend test using the categories as an ordinal variable in the Cox regression model.
  4. cAdjusted for age, body mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0), smoking status (never, former, current, unknown), education (<10, 10–12, 13 years, unknown).